DE69627323D1 - Indazolderivate mit einer cyclischen aminogruppe - Google Patents

Indazolderivate mit einer cyclischen aminogruppe

Info

Publication number
DE69627323D1
DE69627323D1 DE69627323T DE69627323T DE69627323D1 DE 69627323 D1 DE69627323 D1 DE 69627323D1 DE 69627323 T DE69627323 T DE 69627323T DE 69627323 T DE69627323 T DE 69627323T DE 69627323 D1 DE69627323 D1 DE 69627323D1
Authority
DE
Germany
Prior art keywords
amino group
cyclic amino
indazol
derivatives
indazol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69627323T
Other languages
English (en)
Other versions
DE69627323T2 (de
Inventor
Masashi Suzuki
Masahiro Ueno
Ryuta Fukutomi
Hiroaki Satoh
Haruhiko Kikuchi
Koichiro Hagihara
Takeo Arai
Sugure Taniguchi
Setsuko Mino
Yumiko Noguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Application granted granted Critical
Publication of DE69627323D1 publication Critical patent/DE69627323D1/de
Publication of DE69627323T2 publication Critical patent/DE69627323T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69627323T 1995-05-31 1996-05-31 Indazolderivate mit einer cyclischen aminogruppe Expired - Fee Related DE69627323T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15549395 1995-05-31
JP3573996 1996-01-31
PCT/JP1996/001475 WO1996038420A1 (fr) 1995-05-31 1996-05-31 Derives de l'indazole a groupe amino monocyclique

Publications (2)

Publication Number Publication Date
DE69627323D1 true DE69627323D1 (de) 2003-05-15
DE69627323T2 DE69627323T2 (de) 2004-01-15

Family

ID=26374732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627323T Expired - Fee Related DE69627323T2 (de) 1995-05-31 1996-05-31 Indazolderivate mit einer cyclischen aminogruppe

Country Status (6)

Country Link
US (2) US5945434A (de)
EP (1) EP0829474B1 (de)
KR (1) KR19990022096A (de)
CA (1) CA2222532A1 (de)
DE (1) DE69627323T2 (de)
WO (1) WO1996038420A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
JP2005520171A (ja) * 2001-04-10 2005-07-07 トランス　テック　ファーマ，インコーポレイテッド ドラッグディスカバリーに関する、プローブ、システム、および方法
WO2003035005A2 (en) 2001-10-26 2003-05-01 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
ITMI20030287A1 (it) * 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) * 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
ES2332808T3 (es) * 2004-11-05 2010-02-12 Theravance, Inc. Compuestos agonistas del receptor 5-ht4.
EP1807423B1 (de) * 2004-11-05 2009-05-20 Theravance, Inc. Chinolinon-carboxamid-verbindungen
JP5159317B2 (ja) * 2004-12-22 2013-03-06 セラヴァンス， インコーポレーテッド インダゾール−カルボキサミド化合物
US7446114B2 (en) * 2005-03-02 2008-11-04 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
EP1910340B1 (de) * 2005-07-22 2009-11-18 Pfizer, Inc. Indazolcarbonsäureamidderivate als agonisten des 5ht4-rezeptors
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
BR112014018657B1 (pt) * 2012-02-21 2022-08-02 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A Compostos de 1h-indazol-3-carboxamida
CN103012318B (zh) * 2012-11-25 2014-12-10 大理学院 氟苄基取代哌嗪类化合物及其制备和医药用途
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
WO2017066705A1 (en) * 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
NZ230068A (en) * 1988-07-29 1991-07-26 Dainippon Pharmaceutical Co Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
AU2435092A (en) * 1991-08-20 1993-03-16 Smithkline Beecham Plc 5-ht4 receptor antagonists
CA2126354C (en) * 1991-12-21 2006-07-11 Gareth John Sanger Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
JPH06135960A (ja) * 1991-12-25 1994-05-17 Dainippon Pharmaceut Co Ltd インダゾール−３−カルボキサミド誘導体
CA2160420A1 (en) * 1994-10-20 1996-04-21 Haruhiko Kikuchi 5-ht4 receptor agonists
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides

Also Published As

Publication number Publication date
KR19990022096A (ko) 1999-03-25
DE69627323T2 (de) 2004-01-15
WO1996038420A1 (fr) 1996-12-05
EP0829474A1 (de) 1998-03-18
US5945434A (en) 1999-08-31
CA2222532A1 (en) 1996-12-05
US6096746A (en) 2000-08-01
EP0829474A4 (de) 2000-01-26
EP0829474B1 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
DE69627323D1 (de) Indazolderivate mit einer cyclischen aminogruppe
DE69632369D1 (de) HDLC-Anordnung mit verteiltem internen Bus
DE19581549T1 (de) Kraftstoffversorgungssystem
IT1277331B1 (it) Seggiolone a chiusura migliorata
DE59604308D1 (de) Einspritzventil
DE69605190D1 (de) Brennstoff - einspritzung
DE69605168D1 (de) Einspritzventil
DE69611016T2 (de) Treibstoffversorgungssystem
DE69605756D1 (de) Verbinder mit Verriegelungsarm
DE69601012D1 (de) Verbinder mit kappenartigem Rückhalteelement
ATE264874T1 (de) Cyclopeptidderivate
DE69625992D1 (de) Einspritzventil
IS4382A (is) Ný peptíð með ónæmisbreytandi áhrif
DE69604982T2 (de) Brennstoffversorgungssystem
DE69614229T2 (de) Kraftstoffzufuhrsystem
DE59602366D1 (de) Einspritzdüse
DE69604385T2 (de) Isocumarine mit antitumorwirkung
DE59606137D1 (de) Einspritzeinrichtung
DE29506887U1 (de) Gürtel mit einer Schließe
DE69625487T2 (de) Brennstoffzufuhrsystem
DE29506604U1 (de) Fertiginfusionsset
ATA144095A (de) Krümmeranordnung
DE29510171U1 (de) Einrichtung mit einer Massageeinrichtung
KR970024138U (ko) 인젝터
IT1275919B1 (it) Fotodensitometro parallelo perfezionato

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee